Fresenius Medical Care shares tumble 7.6% after Q2 U.S. volume decline

The German dialysis specialist's stock erased most of its gains since the start of the year in European morning trading Tuesday after reporting another drop in U.S. treatment volumes.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.